BABCOCK & WILCOX ENTERPR (BW)

US05614L2097 - Common Stock

1.81  +0.03 (+1.69%)

After market: 1.82 +0.01 (+0.55%)

Fundamental Rating

1

Overall BW gets a fundamental rating of 1 out of 10. We evaluated BW against 89 industry peers in the Electrical Equipment industry. BW has a bad profitability rating. Also its financial health evaluation is rather negative. BW does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

BW had negative earnings in the past year.
In the past year BW has reported a negative cash flow from operations.
In the past 5 years BW reported 4 times negative net income.
In the past 5 years BW always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -9.25%, BW perfoms like the industry average, outperforming 56.82% of the companies in the same industry.
BW has a better Return On Invested Capital (3.02%) than 68.18% of its industry peers.
BW had an Average Return On Invested Capital over the past 3 years of 2.71%. This is significantly below the industry average of 10.49%.
The 3 year average ROIC (2.71%) for BW is below the current ROIC(3.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.25%
ROE N/A
ROIC 3.02%
ROA(3y)-9.65%
ROA(5y)-10.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.91%

1.3 Margins

BW has a Operating Margin of 2.21%. This is in the better half of the industry: BW outperforms 67.05% of its industry peers.
BW's Operating Margin has declined in the last couple of years.
BW has a Gross Margin of 23.73%. This is comparable to the rest of the industry: BW outperforms 56.82% of its industry peers.
In the last couple of years the Gross Margin of BW has declined.
Industry RankSector Rank
OM 2.21%
PM (TTM) N/A
GM 23.73%
OM growth 3Y-8.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BW is destroying value.
BW has more shares outstanding than it did 1 year ago.
BW has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BW has a worse debt to assets ratio.

2.2 Solvency

BW has an Altman-Z score of -1.13. This is a bad value and indicates that BW is not financially healthy and even has some risk of bankruptcy.
BW has a worse Altman-Z score (-1.13) than 67.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.13
ROIC/WACC0.37
WACC8.08%

2.3 Liquidity

A Current Ratio of 1.78 indicates that BW should not have too much problems paying its short term obligations.
With a Current ratio value of 1.78, BW perfoms like the industry average, outperforming 43.18% of the companies in the same industry.
BW has a Quick Ratio of 1.39. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BW (1.39) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.39

1

3. Growth

3.1 Past

BW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.14%.
BW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.50%.
The Revenue has been decreasing by -1.22% on average over the past years.
EPS 1Y (TTM)-141.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
Revenue 1Y (TTM)-16.5%
Revenue growth 3Y20.84%
Revenue growth 5Y-1.22%
Sales Q2Q%-12.32%

3.2 Future

The Earnings Per Share is expected to grow by 29.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, BW will show a decrease in Revenue. The Revenue will decrease by -5.22% on average per year.
EPS Next Y86.08%
EPS Next 2Y41.26%
EPS Next 3Y29.77%
EPS Next 5YN/A
Revenue Next Year-17.81%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.22%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

BW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BW indicates a somewhat cheap valuation: BW is cheaper than 76.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.01

4.3 Compensation for Growth

A more expensive valuation may be justified as BW's earnings are expected to grow with 29.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.26%
EPS Next 3Y29.77%

0

5. Dividend

5.1 Amount

No dividends for BW!.
Industry RankSector Rank
Dividend Yield N/A

BABCOCK & WILCOX ENTERPR

NYSE:BW (1/6/2025, 4:15:01 PM)

After market: 1.82 +0.01 (+0.55%)

1.81

+0.03 (+1.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners77.45%
Inst Owner Change0%
Ins Owners4.26%
Ins Owner Change2.73%
Market Cap170.72M
Analysts81.67
Price Target4.72 (160.77%)
Short Float %2.54%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-24.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1666.99%
Min EPS beat(2)-3783.5%
Max EPS beat(2)449.52%
EPS beat(4)1
Avg EPS beat(4)-1276.14%
Min EPS beat(4)-3783.5%
Max EPS beat(4)449.52%
EPS beat(8)1
Avg EPS beat(8)-737.95%
EPS beat(12)2
Avg EPS beat(12)-512.39%
EPS beat(16)6
Avg EPS beat(16)-334.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.06%
Min Revenue beat(2)-11.29%
Max Revenue beat(2)-4.84%
Revenue beat(4)0
Avg Revenue beat(4)-8.14%
Min Revenue beat(4)-13.93%
Max Revenue beat(4)-2.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.71%
Revenue beat(16)8
Avg Revenue beat(16)1.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48.08%
EPS NY rev (1m)-186.54%
EPS NY rev (3m)-193.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 17.01
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS9.31
BVpS-2.16
TBVpS-3.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.25%
ROE N/A
ROCE 3.82%
ROIC 3.02%
ROICexc 3.22%
ROICexgc 4.16%
OM 2.21%
PM (TTM) N/A
GM 23.73%
FCFM N/A
ROA(3y)-9.65%
ROA(5y)-10.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.91%
ROICexc(3y)3.51%
ROICexc(5y)3.64%
ROICexgc(3y)5.81%
ROICexgc(5y)5.57%
ROCE(3y)3.44%
ROCE(5y)8.52%
ROICexcg growth 3Y8.01%
ROICexcg growth 5YN/A
ROICexc growth 3Y0.31%
ROICexc growth 5YN/A
OM growth 3Y-8.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5YN/A
F-Score3
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 13.24
Cap/Depr 51.43%
Cap/Sales 1.07%
Interest Coverage 0.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.39
Altman-Z -1.13
F-Score3
WACC8.08%
ROIC/WACC0.37
Cap/Depr(3y)46.1%
Cap/Depr(5y)40.64%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
EPS Next Y86.08%
EPS Next 2Y41.26%
EPS Next 3Y29.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.5%
Revenue growth 3Y20.84%
Revenue growth 5Y-1.22%
Sales Q2Q%-12.32%
Revenue Next Year-17.81%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.22%
Revenue Next 5YN/A
EBIT growth 1Y-11.38%
EBIT growth 3Y10.29%
EBIT growth 5YN/A
EBIT Next Year239.91%
EBIT Next 3Y62.58%
EBIT Next 5YN/A
FCF growth 1Y-18.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.37%
OCF growth 3YN/A
OCF growth 5YN/A